Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503542 · ClinicalTrials.gov registry record · Early Phase 1
Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
A Early Phase 1 study, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 46
- Enrollment target
NCT00503542 is a Early Phase 1 study that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 46 participants.
The verdict
NCT00503542, a Early Phase 1 study, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
Many women present in primary care with vaginal complaints. The best way of managing these complaints is unclear. This trial will test two different methods of managing patients with vaginal complaints. This is a pilot trial.
Interventions
- DRUG Terazol or oral fluconazole for candidal vaginitis
- DRUG Metronidazole or Clindamycin for Bacterial Vaginosis
- DRUG Flagyl for definitively diagnosed vaginal trichomoniasis
- OTHER Empiric Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00503542
The ClinicalTrials.gov registry entry for NCT00503542 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agency for Healthcare Research and Quality (AHRQ), which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Terazol or oral fluconazole for candidal vaginitis is the first listed.
NCT00503542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00503542 about?
NCT00503542 is a clinical study titled "Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network". Many women present in primary care with vaginal complaints. The best way of managing these complaints is unclear. This trial will test two different methods of managing patients with vaginal complaints. This is a pilot trial.
What is the current status of trial NCT00503542?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 46 participants. The study started on 2007-02. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00503542?
The interventions under investigation include: Terazol or oral fluconazole for candidal vaginitis (DRUG), Metronidazole or Clindamycin for Bacterial Vaginosis (DRUG), Flagyl for definitively diagnosed vaginal trichomoniasis (DRUG), Empiric Management (OTHER).
Who is sponsoring clinical trial NCT00503542?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.